OCC 20.9% 66.5¢ orthocell limited

FDA significance, page-456

  1. 1,666 Posts.
    lightbulb Created with Sketch. 178
    Mate, PAR has a long time to wait before they
    gain a meaningful return, as a lot of us
    shareholders would attest. A lot of frustration
    going on there too with FDA stalling.

    EMV I know nothing about, but OCC and PAR
    I reckon it’s six of one, half a dozen the other.

    Just IMO.

 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.